Market Context — 2026-08-26 Update (v39)
NVDA earnings (today/Wed) is the week's fulcrum, priced for a 6.5-7% move. Skew still slightly bearish, but sell-side momentum keeps building bullish: Raymond James $352 PT, BMO $340, Bernstein flags Rubin ramp could push the $500B/3yr data center outlook higher, Dan Niles/Goldman cite hyperscaler capex +92% YoY as underappreciated. Mutual fund NVDA underweight remains "off the charts" (Goldman) — positioning not crowded, a bullish asymmetry setup. Custom silicon bifurcation theme keeps widening (Marvell-Google $12.2B warrant, Waymo ASIC, SpaceX/Nvidia Vera Rubin space system, Xiaomi Xring D100, NVDA reportedly in talks to buy/invest in Korea's Rebellions) — infra bull case fundamentally intact. AMD upgraded to Strong Buy by Raymond James ($641 PT) on CPU share-gain thesis vs Intel. Marvell reports Thu (10% implied swing); Broadcom 9/2, with JPMorgan defending its AI competitive moat. Memory bull case strengthens further: Gartner sees semi revenue near-doubling to $1.6T in 2026, SK Hynix $29B buyback, Samsung ~$65-80B returns, Needham raises SK Hynix PT to $220 — though Cathie Wood publicly fades memory (calls HBM pricing a cyclicality warning, not a moat) and Citadel's $4B+ absorption of distressed Micron/Sandisk block trades raises questions about who's really driving the rebound. Intel fell on $20B secondary dilution.
Oil whiplash continues. After Tuesday's 3% drop to 12-day lows on a softer-than-feared sanctions rollout, Iran claims a 2-year resilience plan and China vows to keep buying — the "warning shot not knockout" read holds. But Oman-Iran and Qatar diplomacy toward reopening Hormuz is real and could extend the selloff if it progresses; watch for further downside squeeze in energy/refiners after their 40% YTD run. Diesel cracks near records remain the inflation wildcard even as headline crude eases.
Bond market still the swing factor. 30Y whipsawing 5.19-5.35%, Bessent's doubled buybacks meeting open resistance from Citadel (publicly accused of shorting bonds), Schiff/Druckenmiller skeptical. Fed minutes unchanged (9-3 hold, hawkish undertone, December hike risk). Japan JGB/yen thesis still the top unresolved macro tripwire.
Healthcare/biotech breakout intact but stretched (XBI +34% YTD, Merck/Moderna/Amgen), RSI>70 on several names — pause plausible, trend not broken. Canada trade war escalated (50% auto tariffs confirmed for Jan 2027, Sept 8 retaliation deadline live) despite reports of a possible reprieve deal on Trump's desk — contradictory signals, unresolved. Walmart soft comps confirm consumer softening trend.
Watch: NVDA print (today), Marvell 8/27, Broadcom 9/2, China response to sanctions, Hormuz diplomacy follow-through, 30Y direction, Sept 8 Canada deadline.